PCVX: Vaxcyte Inc. Stocks News on August 17, 2025

PCVX

Insider Monkey

3 months ago

Here’s Why Vaxcyte (PCVX) Sold Off in Q1

PCVX

Insider Monkey

3 months ago

Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back?

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

PCVX

GlobeNewswire

3 months ago

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

PCVX

GlobeNewswire

4 months ago

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

PCVX

Insider Monkey

4 months ago

Is Vaxcyte, Inc. (PCVX) the Best Oversold NASDAQ Stock to Buy Right Now?

PCVX

Simply Wall St.

4 months ago

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans

PCVX

Insider Monkey

4 months ago

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason

PCVX

Zacks

4 months ago

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason

Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI

PCVX

TipRanks

4 months ago

Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI

Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz

PCVX

TipRanks

4 months ago

Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

PCVX

Zacks

5 months ago

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

Vaxcyte stock sinks despite Phase II IPD vaccine trial success

PCVX

Clinical Trials Arena

5 months ago

Vaxcyte stock sinks despite Phase II IPD vaccine trial success

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

PCVX

Investor's Business Daily

5 months ago

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Moderna, biotech stocks slide following resignation of FDA official Peter Marks

PCVX

Yahoo Finance

5 months ago

Moderna, biotech stocks slide following resignation of FDA official Peter Marks

Moderna, biotech stocks slide on resignation of FDA official Peter Marks

PCVX

Yahoo Finance

5 months ago

Moderna, biotech stocks slide on resignation of FDA official Peter Marks

PCVX

MT Newswires

5 months ago

Vaxcyte VAX-24 Vaccine Data Missed Wall Street Expectations, But Fundamentally Still Positive, Mizuho Securities Says

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

PCVX

Investor's Business Daily

5 months ago

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

PCVX

MT Newswires

5 months ago

Sector Update: Health Care Stocks Fall Pre-Bell Monday

PCVX

MT Newswires

5 months ago

Top Premarket Decliners

PCVX

MT Newswires

5 months ago

Vaxcyte's Pneumococcal Conjugate Vaccine Candidate Shows Substantial Immune Response in Infants

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

PCVX

GlobeNewswire

5 months ago

Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

PCVX

Insider Monkey

5 months ago

Vaxcyte, Inc. (PCVX): One of the Best Debt Free Mid Cap Stocks to Buy Now

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

PCVX

GlobeNewswire

5 months ago

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study

PCVX

Insider Monkey

5 months ago

Why Vaxcyte, Inc. (PCVX) Is Among the Best Mid Cap Biotech Stocks to Buy

PCVX

Insider Monkey

5 months ago

Is Vaxcyte, Inc. (PCVX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?

PCVX

Insider Monkey

5 months ago

Vaxcyte (PCVX) Struggled Amid Political Uncertainty

PCVX

MT Newswires

5 months ago

Vaxcyte Insider Sold Shares Worth $353,699, According to a Recent SEC Filing

Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now

PCVX

TipRanks

5 months ago

Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now

PCVX

Insider Monkey

5 months ago

Vaxcyte, Inc. (PCVX): Among the Cash-Rich Mid Cap Stocks to Buy Now

PCVX

Insider Monkey

6 months ago

Why Vaxcyte, Inc. (PCVX) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds

PCVX

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Vaxcyte Inc Earnings Call

PCVX

GuruFocus.com

6 months ago

Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Financial Health and Promising ...

PCVX

MT Newswires

6 months ago

Vaxcyte 2024 Loss Narrows

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

6 months ago

Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

PCVX

Insider Monkey

6 months ago

Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts

It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care

PCVX

Investor's Business Daily

6 months ago

It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

PCVX

GlobeNewswire

6 months ago

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.

PCVX

Investor's Business Daily

6 months ago

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.

PCVX

Insider Monkey

6 months ago

Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts

PCVX

MT Newswires

6 months ago

Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31

PCVX

TipRanks

6 months ago

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants

PCVX

Clinical Trials Arena

6 months ago

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants

PCVX

MT Newswires

6 months ago

Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX

GlobeNewswire

6 months ago

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

PCVX

Zacks

6 months ago

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

PCVX

GlobeNewswire

7 months ago

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

PCVX

Insider Monkey

7 months ago

Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts?

PCVX

MT Newswires

7 months ago

Vaxcyte Insider Sold Shares Worth $427,923, According to a Recent SEC Filing

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

PCVX

Zacks

8 months ago

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

PCVX

Insider Monkey

8 months ago

Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?

PCVX

MT Newswires

8 months ago

Vaxcyte Insider Sold Shares Worth $710,249, According to a Recent SEC Filing

PCVX

Insider Monkey

8 months ago

What Makes Vaxcyte (PCVX) An Investment Bet?

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants

PCVX

Clinical Trials Arena

8 months ago

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX

GlobeNewswire

8 months ago

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

PCVX

Insider Monkey

9 months ago

Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug

PCVX

MT Newswires

9 months ago

Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

PCVX

GlobeNewswire

9 months ago

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

PCVX

Simply Wall St.

9 months ago

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

PCVX

GuruFocus.com

9 months ago

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

9 months ago

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

PCVX

Insider Monkey

10 months ago

Should You Consider Investing in Vaxcyte (PCVX)?

PCVX

MT Newswires

10 months ago

Vaxcyte Insider Sold Shares Worth $4,846,508, According to a Recent SEC Filing

PCVX

MT Newswires

10 months ago

Vaxcyte Insider Sold Shares Worth $6,283,861, According to a Recent SEC Filing

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $927,551, According to SEC Filing

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing

PCVX

Insider Monkey

a year ago

Vaxcyte, Inc. (PCVX): Among Hedge Funds’ Top Biotech Stock Picks

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference

PCVX

GlobeNewswire

a year ago

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference

PCVX

MT Newswires

a year ago

Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating

PCVX

MT Newswires

a year ago

Vaxcyte Closes $1.5 Billion Offering of Shares, Warrants

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

PCVX

GlobeNewswire

a year ago

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise

PCVX

BioPharma Dive

a year ago

Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise

PCVX

MT Newswires

a year ago

Vaxcyte Prices $1.3 Billion Offering of Shares, Warrants

Vaxcyte Announces Pricing of $1.3 Billion Public Offering

PCVX

GlobeNewswire

a year ago

Vaxcyte Announces Pricing of $1.3 Billion Public Offering

Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results

PCVX

Zacks

a year ago

Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results

PCVX

Zacks

a year ago

Company News for Sep 4, 2024

Vaccine Maker Raising $1 Billion Leads Post-Holiday Share Sales

PCVX

Bloomberg

a year ago

Vaccine Maker Raising $1 Billion Leads Post-Holiday Share Sales

PCVX

MT Newswires

a year ago

Vaxcyte Starts $1 Billion Underwritten Public Offering

Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market

PCVX

Investor's Business Daily

a year ago

Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

PCVX

GlobeNewswire

a year ago

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

PCVX

MT Newswires

a year ago

Sector Update: Health Care Stocks Decline Late Afternoon

PCVX

MT Newswires

a year ago

Sector Update: Health Care Stocks Retreat in Afternoon Trading

PCVX

MT Newswires

a year ago

Sector Update: Health Care

Heard on the Street: Pfizer Better Watch Out for This Biotech

PCVX

The Wall Street Journal

a year ago

Heard on the Street: Pfizer Better Watch Out for This Biotech

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher

PCVX

Benzinga

a year ago

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher

Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market

PCVX

Investor's Business Daily

a year ago

Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market

PCVX

MT Newswires

a year ago

Sector Update: Health Care

PCVX

MT Newswires

a year ago

Vaxcyte Plans Phase 3 Trial for 31-Valent Pneumococcal Conjugate Vaccine Candidate After 'Positive' Phase 1/2 Study Results

Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

GlobeNewswire

a year ago

Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

GlobeNewswire

a year ago

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $1,184,767, According to a Recent SEC Filing

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update

PCVX

GlobeNewswire

a year ago

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update

PCVX

GuruFocus.com

a year ago

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)

PCVX

Zacks

a year ago

Wall Street Analysts See a 25.16% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?

PCVX

Zacks

a year ago

Are You Looking for a Top Momentum Pick? Why Vaxcyte, Inc. (PCVX) is a Great Choice

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $1,263,912, According to a Recent SEC Filing

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $649,325, According to a Recent SEC Filing

PCVX

MT Newswires

a year ago

Vaxcyte Insider Sold Shares Worth $425,000, According to a Recent SEC Filing

PCVX

GuruFocus.com

a year ago

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)

Vaxcyte Appoints John Furey to Board of Directors

PCVX

GlobeNewswire

a year ago

Vaxcyte Appoints John Furey to Board of Directors

PCVX

MT Newswires

a year ago

Latest Vaxcyte Inc. (PCVX) News on August 17, 2025

Share on Social Networks: